Wissenschaftl. Titel | Safety and Effectiveness of Ocrelizumab under Real World Conditions: a Non-Interventional Post Authorization Safety Study in Patients Diagnosed with Relapsing or Primary Progressive Multiple Sclerosis (CONFIDENCE) |
Erkrankung |
Nervensystem:
Multiple Sklerose
|
weitere Prüfzentren | |
Kurzprotokoll | Kurzprotokoll |
erstellt 11.08.2021 Nicole Wamser
geändert 13.06.2024 Admin03